| | Class 2 Device Recall Helix Elite |  |
| Date Initiated by Firm | February 25, 2022 |
| Create Date | March 14, 2022 |
| Recall Status1 |
Terminated 3 on January 16, 2024 |
| Recall Number | Z-0784-2022 |
| Recall Event ID |
89694 |
| Product Classification |
Multi-analyte controls unassayed - Product Code OHQ
|
| Product | Mycoplasma genitalium Control Panel (Inactivated Pellet) |
| Code Information |
Catalog 8240, Lots: 8240-08, 8240-09, 8240-10, 8240-11, 8240-12, 8240-13, 8240-14, 8240-15, 8240-16 (UDI: 70845357043053) |
| FEI Number |
2150138
|
Recalling Firm/ Manufacturer |
Microbiologics Inc 200 Cooper Ave N Saint Cloud MN 56303-4440
|
| For Additional Information Contact | Becky Neu 320-229-7073 |
Manufacturer Reason for Recall | Distributed product did not undergo proper release testing. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | All consignees were contacted beginning 02/25/2022 via email. Consignees should read the recall instructions and determine if the product can be used or discarded, depending on user's lab procedures. A response form should be completed and returned to recall@microbiologics.com. |
| Quantity in Commerce | 80 units |
| Distribution | Distribution in US: AZ, CT, DC, FL, IL, IN, KS, KY, MA, MD, NC, NH, NJ, NY, PA, TX, UT, WA
OUS distribution to Belgium, Finland, France, Germany, Ireland, Sweden, United Kingdom, and Vietnam |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|